RecruitingNCT05241418

Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease


Sponsor

Boston Children's Hospital

Enrollment

50 participants

Start Date

Mar 23, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.


Eligibility

Min Age: 13 Years

Inclusion Criteria1

  • Patients >13 years old with congenital heart disease referred for cardiac MRI and receiving gadolinium as part of routine clinical care or for pre-ablation planning will be included.

Exclusion Criteria1

  • Those with self-reported anxiety or claustrophobia and/or the presence of a permanent pacemaker or implantable cardioverter defibrillator will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAtrial 3D late gadolinium enhancement

We will use cardiac MRI to take a picture of the atria. This picture will be used to identify scar tissue within the atria.


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05241418


Related Trials